Initial Management of Acute Congestive Heart Failure in Elderly Patients

Immediate Assessment and Triage

The European Society of Cardiology recommends rapidly assessing severity to determine level of care, with high-risk features requiring ICU/CCU admission including respiratory rate >25/min, SpO2 <90% despite oxygen, systolic BP <90 mmHg, use of accessory breathing muscles, altered mental status, or signs of hypoperfusion 1, 2
The European Heart Association suggests that moderate-risk patients without these features can be managed in monitored ward settings with cardiology consultation 1
Continuous monitoring (pulse oximetry, blood pressure, ECG, respiratory rate) should be initiated immediately upon patient contact, as recommended by the European Heart Journal 2

The European Journal of Heart Failure recommends providing oxygen therapy if SpO2 <90%, but avoiding hyperoxia 3, 2
Non-invasive ventilation (CPAP or BiPAP) should be started immediately in patients with respiratory distress, as this reduces intubation rates and may reduce mortality, according to the European Journal of Heart Failure 3, 2
CPAP is simpler and feasible even in pre-hospital settings, as stated by the European Journal of Heart Failure 3

The European Society of Cardiology recommends first-line treatment with IV vasodilators (nitroglycerin or nitroprusside) plus IV diuretics (furosemide) for patients with systolic blood pressure >110 mmHg 3, 2
IV furosemide should be started with 40 mg IV bolus if diuretic-naïve, or at least double the chronic oral dose if already on diuretics, as recommended by the European Journal of Heart Failure 3, 2
Diuretics remain first-line therapy for patients with systolic blood pressure <110 mmHg, but vasodilators should be avoided, according to the European Journal of Heart Failure 3, 2

The European Heart Journal suggests that thiazide diuretics are often ineffective due to reduced GFR; loop diuretics should be used instead 4, 5
The European Heart Journal recommends monitoring closely for hyperkalemia when combining ACE inhibitors/ARBs with aldosterone antagonists, especially in presence of renal dysfunction 4, 5
Routine morphine use should be avoided, as it is associated with higher rates of mechanical ventilation, ICU admission, and death in registry data, according to the European Journal of Heart Failure 3

The European Journal of Heart Failure recommends rechecking urine output, respiratory rate, and blood pressure response within 2-6 hours 1, 2, 3
Renal function (creatinine, BUN) and electrolytes (potassium, sodium, bicarbonate) should be assessed within 24-48 hours, as recommended by the European Heart Journal 4, 5

The European Heart Journal suggests scheduling the first follow-up within 10 days of discharge to assess medication tolerance, symptom improvement, and laboratory parameters 4, 5
Guideline-directed medical therapy (ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists) should be initiated or optimized before discharge at low doses with a plan for gradual titration, according to the European Heart Journal 4, 5

The European Society of Cardiology recommends essential laboratory tests, including complete blood count, urinalysis, serum electrolytes, BUN, creatinine, fasting glucose, lipid profile, liver function tests, and thyroid-stimulating hormone, to identify precipitating factors and comorbidities common in elderly patients 6
The American Heart Association suggests obtaining 12-lead ECG and chest radiograph (PA and lateral) in all patients, and performing 2D echocardiography with Doppler to assess LVEF, LV size, wall thickness, and valve function, which determines whether heart failure is systolic or diastolic 6

The European Heart Journal recommends starting ACE inhibitors (or ARBs if ACE-intolerant) at low doses before discharge with a plan for gradual titration, and notes that these medications are effective and well-tolerated in elderly patients 7
The European Heart Journal suggests initiating beta-blockers at low doses with gradual titration, excluding patients with sick sinus node, AV-block, or obstructive lung disease, and notes that beta-blockers should not be withheld based on age alone 7

The European Heart Journal recommends using diuretics cautiously and only for symptomatic fluid overload, as excessive preload reduction can paradoxically reduce stroke volume and cardiac output, especially in diastolic dysfunction 7
The European Heart Journal suggests avoiding NSAIDs and COX-2 inhibitors, as they are common precipitants of CHF exacerbations and increase hyperkalemia risk when combined with aldosterone antagonists and ACE inhibitors 7

The European Heart Journal recommends a multidisciplinary team with vigilant follow-up, discharge planning, optimized medical therapy, intense education and counseling, attention to behavioral strategies, and early attention to signs and symptoms 7
The European Heart Journal suggests considering telemonitoring and flexible diuretic regimens, and notes that relief of symptoms rather than prolongation of life may be the most important goal for many older patients 7